Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway. 由 McClements, L, Yakkundi, A, Papaspyropoulos, A, Harrison, H, Ablett, M, Jithesh, P, McKeen, H, Bennett, R, Donley, C, Kissenpfennig, A, McIntosh, S, McCarthy, H, O'Neill, E, Clarke, R, Robson, T